Hospital-acquired renal insufficiency: a prospective study SH Hou, DA Bushinsky, JB Wish, JJ Cohen, JT Harrington The American journal of medicine 74 (2), 243-248, 1983 | 1716 | 1983 |
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors MR Weir, GL Bakris, DA Bushinsky, MR Mayo, D Garza, Y Stasiv, J Wittes, ... New England Journal of Medicine 372 (3), 211-221, 2015 | 680 | 2015 |
Sustained, long-term renal stabilization after 54 months of agalsidase β therapy in patients with Fabry disease DP Germain, S Waldek, M Banikazemi, DA Bushinsky, J Charrow, ... Journal of the American Society of Nephrology 18 (5), 1547-1557, 2007 | 542 | 2007 |
Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial GL Bakris, B Pitt, MR Weir, MW Freeman, MR Mayo, D Garza, Y Stasiv, ... Jama 314 (2), 151-161, 2015 | 468 | 2015 |
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF … B Pitt, SD Anker, DA Bushinsky, DW Kitzman, F Zannad, IZ Huang European heart journal 32 (7), 820-828, 2011 | 453 | 2011 |
Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro NS Krieger, NE Sessler, DA Bushinsky American Journal of Physiology-Renal Physiology 262 (3), F442-F448, 1992 | 391 | 1992 |
Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes AJ Collins, B Pitt, N Reaven, S Funk, K McGaughey, D Wilson, ... American journal of nephrology 46 (3), 213-221, 2017 | 355 | 2017 |
Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts DA Bushinsky American Journal of Physiology-Renal Physiology 271 (1), F216-F222, 1996 | 331 | 1996 |
Bone buffering of acid and base in humans J Lemann Jr, DA Bushinsky, LL Hamm American Journal of Physiology-Renal Physiology 285 (5), F811-F832, 2003 | 323 | 2003 |
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease LD Quarles, DJ Sherrard, S Adler, SJ Rosansky, LC McCary, W Liu, ... Journal of the American Society of Nephrology 14 (3), 575-583, 2003 | 319 | 2003 |
Acid-base imbalance and the skeleton DA Bushinsky European journal of nutrition 40, 238-244, 2001 | 287 | 2001 |
Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial GA Block, DA Bushinsky, S Cheng, J Cunningham, B Dehmel, TB Drueke, ... Jama 317 (2), 156-164, 2017 | 286 | 2017 |
Mechanism of acid-induced bone resorption NS Krieger, KK Frick, DA Bushinsky Current opinion in nephrology and hypertension 13 (4), 423-436, 2004 | 284 | 2004 |
Left ventricular contractility varies directly with blood ionized calcium RM LANG, SK FELLNER, A NEUMANN, DA BUSHINSKY, KM BOROW Annals of internal medicine 108 (4), 524-529, 1988 | 218 | 1988 |
Molecular mechanisms of primary hypercalciuria KK Frick, DA Bushinsky Journal of the American Society of Nephrology 14 (4), 1082-1095, 2003 | 202 | 2003 |
The effects of acid on bone DA Bushinsky, KK Frick Current opinion in nephrology and hypertension 9 (4), 369-379, 2000 | 199* | 2000 |
Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics R Terkeltaub, DA Bushinsky, MA Becker Arthritis Research & Therapy 8, 1-9, 2006 | 195 | 2006 |
Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. XQ Li, V Tembe, GM Horwitz, DA Bushinsky, MJ Favus The Journal of clinical investigation 91 (2), 661-667, 1993 | 187 | 1993 |
Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials GA Block, DA Bushinsky, J Cunningham, TB Drueke, M Ketteler, ... Jama 317 (2), 146-155, 2017 | 173 | 2017 |
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors B Pitt, GL Bakris, DA Bushinsky, D Garza, MR Mayo, Y Stasiv, ... European journal of heart failure 17 (10), 1057-1065, 2015 | 172 | 2015 |